Dr. Flexner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Baltimore, MD 21287Phone+1 410-955-5000Fax+1 410-955-5001
Education & Training
- Johns Hopkins UniversityFellowship, Infectious Disease, 1988 - 1989
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1985 - 1987
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1982 - 1985
- Johns Hopkins University School of MedicineClass of 1982
Certifications & Licensure
- CA State Medical License 1983 - Present
- MD State Medical License 1985 - 2026
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals
- A Phase I Randomized Dose/Formulation Comparison Study of SC-52151
- Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults
- Join now to see all
Publications & Presentations
PubMed
- Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.N Sarita Shah, Cissy Kityo, Michael D Hughes, Caitlyn McCarthy, Carole Wallis
Clinical Infectious Diseases. 2024-05-13 - 2 citationsConstructing Antiretroviral Supramolecular Polymers as Long-Acting Injectables through Rational Design of Drug Amphiphiles with Alternating Antiretroviral-Based and Hy...Han Wang, Maya K Monroe, Feihu Wang, Mingjiao Sun, Charles Flexner
Journal of the American Chemical Society. 2023-10-04 - 10 citationsInterleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.Nicholas T Funderburg, Carey L Shive, Zhengyi Chen, Curtis Tatsuoka, Emily R Bowman
Clinical Infectious Diseases. 2023-07-26
Journal Articles
- Effect of Antiretroviral Therapy on Plasma Concentrations of Chloroquine and Desethyl-ChloroquineCharles Flexner, Michael M Lederman, Theresa A Shapiro, Clinical Infectious Diseases
Lectures
- Modern HIV Therapy: Progress and ProspectsVirology Education B.V, Baltimore, Maryland - 11/5/2012
Other
- Modern HIV Therapy: Progress and ProspectsCharles Flexner, MD, Clinical Pharmacology & Therapeutics
https://www.doximity.com/articles/d00fecdd-81cc-4143-b68b-e4c067729426
UpToDate, Wolters Kluwer Health - 2012-08-16
Press Mentions
- Management of Patients with HIV, Limited Treatment OptionsOctober 26th, 2022
- New Approaches to HIV Prevention, Management of Patients with HIVOctober 25th, 2022
- Forty Years on, Black Americans Disproportionately Hit by HIVMay 6th, 2021
- Join now to see all
Grant Support
- Johns Hopkins AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
- ACTG A5128National Center For Research Resources2005–2007
- ACTG A5191National Center For Research Resources2004–2007
- ACTG A5001National Center For Research Resources2004–2007
- ACTG 362National Center For Research Resources2004–2007
- ACTG A5223National Center For Research Resources2006
- Johns Hopkins Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2001–2006
- Oral ClotrimazoleNational Center For Research Resources2004–2005
- Interaction Of Amprenavir (Apv), Lopinavir (Lpv/R), And Efavirenz (EFV)National Center For Research Resources2004–2005
- ACTG Screening ConsentNational Center For Research Resources2004–2005
- ACTG 5077: Virologic StudiesNational Center For Research Resources2004–2005
- Antiretroviral Response To Idv/Rtv Containing Regimen In Hiv-Infected SubjectsNational Center For Research Resources2004
- ACTG A5043National Center For Research Resources2004
- ACTG 384National Center For Research Resources2004
- ACTG 372National Center For Research Resources2004
- A5058s: Augmentation Of Hiv-Specific Helper And CTL Response Through TherapeuticNational Center For Research Resources2004
- Trial Of Hydroxyurea In Combo With Antivirals In HIVNational Center For Research Resources2000–2002
- Trial Of Efv/Nfv In Combo With Zdv/3tc/Idv In AIDSNational Center For Research Resources2000–2002
- Protease/Nonnucleoside Transcriptase/Nucleoside HIV TherNational Center For Research Resources2000–2002
- Pharmacokinetic Action--Protease Inhibitors &AntilipidsNational Center For Research Resources2000–2002
- Nelfinavir Induced Diarrhea--Secretory VS NonsecretoryNational Center For Research Resources2000–2002
- HIV Protease Inhibitor &Methadone Metabolism In HIVNational Center For Research Resources2000–2002
- Fluconazole VS Episodic In HIV+ PTS With CandidiasisNational Center For Research Resources2000–2002
- Blood Lymphocytes From Hiv--Coreceptor Virus IsolationNational Center For Research Resources2000–2002
- Amprenavir In Combo With Abacavir/Efavirenz/AdefovirNational Center For Research Resources2000–2002
- ACTG 892--Antiretroviral Therapy Effects On Lean BodyNational Center For Research Resources2000–2002
- ACTG 365--Pharmacokinetics On Indinavir And RifabutinNational Center For Research Resources2000–2002
- Safety And Efficacy Of Ritonavir In Combination With Nelfinavir In HIVNational Center For Research Resources1998–2002
- Safety And Antiretroviral Activity Of Hydroxurea And DidanosineNational Center For Research Resources1998–2002
- ACT 307--Safety/Antiretrovirl Activity Of Hydroxyurea Alone/Combination With DDINational Center For Research Resources1998–2002
- ACTG 307 Dosing Study--Safety &Antiretroviral Activity Of HydroxyureaNational Center For Research Resources1999
- Preliminary Antiviral Activity Study Of GEM 91 Administered To HIV+ SubjectsNational Center For Research Resources1998–1999
- Phase I/II Multiple Dose Study Of GEM 91 Continuous IV Infusion In HIV+ PatientsNational Center For Research Resources1998–1999
- Phase I/II Protocol To Evaluate Electroinserted Rbc-Rcd4 In HIV SubjectsNational Center For Research Resources1997–1999
- Rifabutin And Ethambutol Effects On Clarithromycin PharmacokineticsNational Center For Research Resources1997
- Pharmacokinetics &Preliminary Antiviral Activity Study Of GEM 91National Center For Research Resources1997
Other Languages
- Italian
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/charles-flexner
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: